id_pmc	sentence location	highlighted phrase	protein entities found	number of protein entities
6303473	abstract	Structure|of|a|cross-reactive|TCR-HLA-B37-NP|338|complex|suggest|that|the|conserve|conformation|of|the|variant|underpin|TCR|cross-reactivity|.	cross-reactive|TCR-HLA-B37-NP|338|complex|TCR	5
6303473	body	Our|structural|analysis|reveal|that|the|variant|adopt|a|similar|conformation|than|the|WT|epitope|for|both|HLA-A|*|01-01|(|HLA-A1|)|and|HLA-B|*|37-01|(|HLA-B37|)|molecule|,|provide|a|molecular|basis|for|CD8|TCRαβ|cross-reactivity|.	WT|epitope|HLA-A|HLA-A1|HLA-B|HLA-B37|CD8	7
6303473	body	Structural|analysis|indicate|that|molecular|similarity|may|underpin|how|an|HLA-B37-restricted|cross-reactive|TCRαβ|,|clone|EM2|,|can|recognize|the|variant|.		0
6303473	body	Thus|our|datum|suggest|that|structural|resemblance|underpin|cross-reactivity|of|HLA-B37|NP|338|CD8|and|HLA-A1|NP|44|CD8|T|cell|,|despite|their|diverse|TCR|repertoire|between|individual|towards|those|two|epitope|.	HLA-B37|NP|338|CD8|HLA-A1|TCR|epitopes	7
6303473	body	Result|Only|HLA-B37|donor|elicit|a|NP|388|CD8|T|cell|response|Our|previous|work|identify|NP|338|as|an|immunodominant|CD8|T|cell|epitope|in|individual|express|HLA-B37|.	NP|338|immunodominant|CD8|T|cell|epitope|HLA-B37	8
6303473	body	A|high|prediction|binding|score|for|the|NP|338|peptide|be|obtain|for|HLA-B37|,|HLA-B|*|44-02|,|and|HLA-B|*|18-01|(|HLA-B18|)|(|Table|)|.	HLA-B37|HLA-B|HLA-B|HLA-B18	4
6303473	body	Allele|in|bold|be|select|for|further|analysis|We|first|refolde|the|NP|338|peptide|with|HLA-B37|,|HLA-B18|,|and|HLA-B44|molecule|and|assess|the|stability|of|each|peptide–HLA|(|pHLA|)|complex|.	HLA-B37|HLA-B18|HLA-B44|molecules|peptide–HLA|(|pHLA|)|complex	9
6303473	body	The|NP|338|peptide|could|bind|each|of|the|three|HLA|molecule|(|HLA-B37|,|-B18|,|and|-B|*|44|:|05|)|;|however|,|the|stability|of|HLA-B37-NP|338|be|superior|by|6|°C|to|HLA-B18-NP|338|and|by|14|°C|to|HLA-B|*|44-05-NP|338|(|Supplementary|Table|)|.	HLA|molecules|HLA-B37|-B18|HLA-B	5
6303473	body	We|then|solve|the|binary|structure|of|the|NP|338|peptide|present|by|HLA-B37|,|HLA-B18|,|and|HLA-B44|(|Supplementary|Table|,|Fig|.	HLA-B37|HLA-B18|HLA-B44	3
6303473	body	The|NP|338|peptide|adopt|an|extend|conformation|in|the|cleft|of|HLA-B37|,|with|the|P2-Glu|and|P9-Phe|act|as|anchor|residue|in|the|B-|and|F-pocket|of|HLA-B37|,|respectively|.	HLA-B37|HLA-B37	2
6303473	body	In|addition|to|the|primary|anchor|residue|,|the|P5-Arg|act|as|a|secondary|anchor|residue|,|fully|bury|into|the|F-pocket|,|and|form|a|salt|bridge|with|Asp77|from|the|α1-helix|in|the|HLA-B37|molecule|(|Fig|.	Asp77|α1-helix|HLA-B37|molecule	4
6303473	body	Comparison|of|the|HLA-B37-NP|338|with|HLA-B18-NP|338|and|HLA-B44-NP|338|complex|show|an|overall|similar|HLA-binding|cleft|(|Fig|.	HLA-B37-NP|338|HLA-B18-NP|338|HLA-B44-NP|338|complexes	7
6303473	body	Similar|to|the|HLA-B37-NP|338|structure|,|the|NP|338|peptide|be|anchor|to|HLA-B18|and|HLA-B44|by|P2-Glu|and|P9-Phe|.	HLA-B18|HLA-B44	2
6303473	body	However|,|the|NP|338|peptide|adopt|a|strikingly|distinct|conformation|when|bind|to|HLA-B37|as|compare|with|HLA-B18|(|r.m.s.d|.	HLA-B37|HLA-B18	2
6303473	body	The|HLA-B18|contain|a|small|Ser116|,|while|the|HLA-B37|have|a|large|Phe116|.	HLA-B18|HLA-B37	2
6303473	body	As|a|result|,|P9-Phe|of|the|peptide|be|anchor|deeply|in|the|cleft|in|the|HLA-B18|molecule|,|which|would|sterically|clash|with|the|P5-Arg|conformation|observe|in|HLA-B37|.	HLA-B18|molecule|HLA-B37	3
6303473	body	In|addition|,|the|salt|bridge|observe|in|HLA-B37|between|Asp77|and|P5-Arg|would|be|lack|in|HLA-B18|due|to|the|presence|of|Ser77|.	HLA-B37|Asp77|HLA-B18|Ser77	4
6303473	body	On|one|hand|,|the|NP|338|peptide|reveal|a|hydrophobic|surface|when|bind|to|HLA-B37|,|while|on|the|other|,|it|be|an|epitope|with|central|positively|charge|residue|in|the|cleft|of|HLA-B18|and|HLA-B44|.	HLA-B37|epitope|HLA-B18|HLA-B44	4
6303473	body	Follow|10–16|day|of|peptide|stimulation|,|we|detect|robust|CD8|T|cell|response|by|interferon-γ|(|IFNγ|)|and|tumor|necrosis|factor-α|(|TNFα|)|production|as|well|as|CD107a|expression|in|the|majority|(|4|/|5|)|of|HLA-B37|donor|(|Fig|.	IFNγ|TNFα|CD107a	3
6303473	body	The|first|three|row|in|italic|represent|sequence|choose|for|further|analysis|Overall|,|these|datum|suggest|that|HLA-B37|,|but|not|HLA-B44|or|HLA-B18|,|represent|the|HLA|restriction|for|the|NP|338|peptide|.	HLA-B37|HLA-B44|HLA-B18	3
6303473	body	The|lack|of|NP|338|CD8|T|cell|response|in|the|context|of|HLA-B44|and|HLA-B18|might|be|due|to|the|distinct|conformation|,|or|low|stability|,|of|NP|338|as|compare|to|HLA-B37|.	HLA-B44|HLA-B18|NP|338|HLA-B37	5
6303473	body	Cross-reactive|NP|338|CD8|T|cell|towards|NP|338|variant|Have|show|robust|NP|338|CD8|T|cell|response|in|HLA-B37|donor|,|we|next|determine|the|level|of|cross-recognition|towards|the|main|NP|338|variant|occur|in|IAV|.	NP|338|variants|IAVs	4
6303473	body	To|assess|the|cross-reactive|potential|of|HLA-B37-NP|338|CD8|T|cell|,|pooled|or|variant-specific|NP|338|T|cell|line|be|generate|use|PBMC|from|HLA-B37|donor|.		0
6303473	body	We|also|generate|HLA-B37-NP|338|and|mutant|HLA-B37-NP|338|-V6L|and|HLA-B37-NP|338|-L7S|tetramer|.	HLA-B37-NP|338|-L7S|tetramers	4
6303473	body	Our|datum|show|that|HLA-B37|individual|display|polyfunctional|and|highly|cross-reactive|CD8|T|cell|response|to|the|NP|338|epitope|and|its|major|variant|.	NP|338|epitope	3
6303473	body	NP|338|variant|be|molecular|mimic|of|the|WT|NP|338|epitope|To|understand|the|molecular|basis|of|HLA-B37-NP|338|CD8|T|cell|cross-reactivity|,|we|solve|the|structure|of|two|major|NP|338|variant|,|namely|,|NP|338|-V6L|and|NP|338|-L7S|in|complex|with|HLA-B37|(|Fig|.	NP|338|variants|WT|NP|338|epitope|NP|338|variants|NP|338|-V6L|NP|338|-L7S|HLA-B37	17
6303473	body	Both|peptide|bind|HLA-B37|in|an|extend|conformation|with|the|canonical|P2-Glu|and|P9-Phe|,|while|P5-Arg|act|as|a|secondary|anchor|residue|(|Fig|.	HLA-B37	1
6303473	body	Superimposition|of|the|HLA-B37-NP|338|binding|cleft|with|either|HLA-B37-NP|338|-V6L|(|Fig|.|)	HLA-B37-NP|338|binding|cleft|HLA-B37-NP|338|-V6L	7
6303473	body	or|HLA-B37-NP|338|-L7S|(|Fig|.|)	HLA-B37-NP|338|-L7S	3
6303473	body	The|substitution|of|P6-Val|for|P6-Leu|in|the|H3N2|be|readily|accommodate|in|the|HLA-B37|cleft|and|do|not|change|either|the|peptide|or|HLA|conformation|(|Fig|.		0
6303473	body	We|also|show|that|the|two|NP|338|variant|could|stabilize|HLA-B37|as|efficiently|as|the|NP|338|WT|peptide|(|Supplementary|Table|)|.	NP|338|variants|HLA-B37	4
6303473	body	Key|TCRs|cross-recognize|NP|338|variant|directly|ex|vivo|To|investigate|HLA-B37-NP|338|CD8|T|cell|cross-reactivity|at|a|molecular|level|,|PBMC|from|healthy|HLA-B37|donor|(|n|=|3|)|be|stain|with|WT|and|variant|HLA-B37-NP|338|tetramer|individually|,|magnetically|enrich|,|and|single-cell|sort|.	TCRs|HLA-B37-NP|338|tetramers	4
6303473	body	CD8|T|cell|direct|at|the|HLA-B37-NP|338|epitope|in|healthy|donor|be|of|the|memory|phenotype|characterize|by|CD27|and|CD45RA|expression|(|Fig|.	HLA-B37-NP|338|epitopes|CD27|CD45RA	5
6303473	body	Together|,|these|datum|highlight|the|potential|of|common|HLA-B37-NP|338|CD8|TCRαβ|clonotype|to|provide|protection|against|distinct|IAV|strain|.		0
6303473	body	A|single|TCRαβ|clonotype|(|term|EM2|:|TRAV30|/|TRBV19|,|CDR3α|:|CGTERSGGYQKVTF|,|and|CDR3β|:|CASSMSAMGTEAFF|)|be|able|to|cross-react|with|all|three|NP|338|peptide|,|therefore|provide|universal|HLA-B37-NP|338|CD8|recognition|.	EM2|TRAV30|TRBV19|CDR3α|CGTERSGGYQKVTF|CDR3β|CASSMSAMGTEAFF	7
6303473	body	Bias|TRBV19|TCR|chain|mainly|contact|the|HLA-B37|To|further|understand|the|molecular|mechanism|underlie|T|cell|cross-reactivity|,|we|then|investigate|the|cross-reactive|clonotype|describe|above|(|EM2|TCR|;|TRAV30|/|TRBV19|,|Supplementary|Table|)|that|be|able|to|recognize|NP|338|and|its|two|most|common|variant|.	TRBV19|TCR|chains|HLA-B37|TCR|TRAV30|TRBV19|NP|338	9
6303473	body	We|solve|the|structure|of|the|EM2|TCR|in|complex|with|HLA-B37-NP|338|(|Supplementary|Table|,|Fig|.	TCR	1
6303473	body	The|EM2|TCR|dock|centrally|onto|HLA-B37-NP|338|with|a|66°|angle|(|Fig|.	TCR	1
6303473	body	)|,|while|the|biased|TRBV19|β-chain|contribute|to|60|%|of|the|BSA|,|provide|a|direct|basis|for|the|TRBV19|bias|observe|in|HLA-B37|donor|in|response|to|NP|338|and|its|variant|.	biased|TRBV19|β-chain|BSA|NP|338	6
6303473	body	All|of|the|CDR|loop|of|the|EM2|TCR|contact|the|HLA-B37|molecule|(|Fig|.	CDR|loops|TCR|HLA-B37|molecule	5
6303473	body	The|FW|residue|Lys83β|form|a|network|of|salt|bridge|with|the|HLA-B37|Glu76|and|CDR1β|Asp30|,|hover|above|P8-Ser|(|Fig|.	HLA-B37|CDR1β|Asp30	3
6303473	body	The|residue|Gln67β|from|the|FW|,|located|downstream|of|the|CDR2β|loop|be|also|contact|the|α1-helix|of|the|HLA-B37|molecule|.	CDR2β|HLA-B37|molecule	3
6303473	body	Gln57β|,|Asn60β|,|Asp61β|,|and|Gln67β|be|form|a|large|hydrogen|network|with|the|HLA-B37|molecule|.	Gln57β|Asn60β|Asp61β|Gln67β|HLA-B37|molecule	6
6303473	body	Overall|,|CDR2β|and|FWβ|make|extensive|interaction|with|the|HLA-B37|molecule|,|provide|a|basis|for|the|strong|bias|TRBV19|usage|observe|in|the|donor|.	CDR2β|HLA-B37|molecule	3
6303473	body	Interestingly|,|the|comparison|of|HLA-B37-NP|338|in|its|free|and|liganded|state|with|the|EM2|TCR|reveal|that|the|peptide|(|r.m.s.d|.	HLA-B37-NP|338|TCR	3
6303473	body	of|0.2|Å|)|and|HLA-B37|(|r.m.s.d|.	HLA-B37	1
6303473	body	The|hydrophobic|nature|of|the|interaction|between|the|EM2|TCR|and|the|NP|338|peptide|be|complementary|with|the|conformation|of|the|NP|338|peptide|bind|to|HLA-B37|that|present|only|the|hydrophobic|residue|to|the|TCR|.	TCR|HLA-B37|TCR	3
6303473	body	Altogether|,|the|structure|of|the|EM2|TCR–HLA-B37-NP|338|complex|reveal|that|the|TCR|be|use|hydrophobic|interaction|from|its|CDR3|loop|to|engage|with|the|all|stretch|of|the|NP|338|peptide|.	EM2|TCR–HLA-B37-NP|338|complex|TCR|CDR3	6
6303473	body	The|EM2|TCR|bind|to|the|HLA-B37-NP|338|complex|with|a|K|d|of|~130|µM|(|Fig|.	TCR|HLA-B37-NP|338|complex	4
6303473	body	The|EM2|TCR|bind|to|NP|338|-L7S|with|a|similar|affinity|to|the|one|observe|for|the|NP|338|bind|to|HLA-B37|(|K|d|~|150|µM|,|Fig|.	TCR|NP|338|-L7S|NP|338|HLA-B37	7
6303473	body	compare|to|NP|338|when|bind|to|HLA-B37|.	NP|338|HLA-B37	3
6303473	body	The|structure|of|each|NP|338|and|variant|in|complex|with|the|HLA-B37|molecule|(|Fig|.	NP|338|HLA-B37|molecule	4
6303473	body	Overlay|of|the|HLA-B37-NP|338|-L7S|with|the|EM2|TCR-HLA-B37-NP|338|structure|show|that|the|small|P7-Ser|would|be|readily|accommodate|by|the|EM2|TCR|without|structural|change|(|Fig|.	HLA-B37-NP|338|-L7S|TCR	4
6303473	body	In|a|similar|fashion|,|an|overlay|of|the|HLA-B37-NP|338|-V6L|with|the|EM2|TCR-HLA-B37-NP|338|structure|(|Fig|.|)	HLA-B37-NP|338|-V6L	3
6303473	body	show|that|the|large|side|chain|of|the|P7-Leu|might|create|additional|contact|with|the|CDR3β|loop|and|might|in|turn|provide|a|basis|for|the|improved|affinity|observe|for|the|EM2|TCR|towards|the|HLA-B37-NP|338|-V6L|(|K|d|~|30|µM|)|.	CDR3β|TCR	2
6303473	body	In|similar|fashion|as|HLA-B37|and|the|NP|338|variant|,|the|NP|44|variant|adopt|similar|conformation|in|the|cleft|of|HLA-A1|molecule|.	HLA-B37|HLA-A1|molecule	3
6303473	body	Overall|,|these|datum|show|that|TCRαβ|cross-reactivity|be|not|limit|to|the|recognition|of|HLA-B37-NP|338|and|highlight|the|importance|of|cross-reactive|CD8|T|cell|in|the|recognition|of|virus-infected|cell|and|thus|their|potential|to|protect|against|distinct|IAV|strain|.	TCRαβ	1
6303473	body	To|understand|the|molecular|basis|of|cross-reactive|TCRαβ|recognition|,|we|solve|the|structure|of|NP|338|and|its|variant|bind|to|the|HLA-B37|molecule|,|as|well|as|the|structure|of|a|cross-reactive|TCR|in|complex|with|HLA-B37-NP|338|.	NP|338|HLA-B37|molecule|TCR|HLA-B37-NP|338	7
6303473	body	The|structure|also|demonstrate|that|only|HLA-B37|,|and|not|HLA-B18|nor|HLA-B44|,|bind|the|NP|338|with|a|secondary|anchor|residue|(|P5-Arg|)|,|reveal|the|hydrophobic|surface|of|the|NP|338|peptide|,|which|might|help|cross-reactivity|.	HLA-B37|HLA-B18|HLA-B44|NP|338	5
6303473	body	Together|,|these|datum|imply|that|HLA-B37|donor|may|have|a|level|of|protection|against|H1N1|,|pH1N1|,|H3N2|,|H5N1|,|H7N9|,|and|possibly|novel|IAV|strain|.	H1N1|pH1N1	2
6303473	body	Additionally|,|we|have|show|that|cross-reactivity|towards|distinct|IAV|strain|be|not|limit|to|HLA-B37-NP|338|,|and|cross-reactive|TCR|towards|the|HLA-A1-restricted|NP|44|be|also|observe|.	IAV|strains|TCRs|NP|44	5
6303473	body	Overall|,|our|study|provide|evidence|that|inter-epitope|cross-reactivity|be|common|for|the|human|influenza|epitope|and|occur|for|prominent|HLA-B37-restricted|NP|338|and|HLA-A1-restricted|NP|44|epitope|,|in|addition|to|previously|publish|HLA-A|*|02-01-restricted|M1|58|.	human|influenza|epitopes|HLA-A1-restricted|NP|44|epitopes|HLA-A	8
6303473	body	CD8|T|cell|can|recognize|variation|within|CD8|T|cell|epitope|and|cross-reactive|CD8|TCRαβ|repertoire|can|recognize|variant|HLA-B37-restricted|NP|338|and|HLA-A1-restricted|NP|44|peptide|across|donor|.	CD8|T|cell|epitopes|cross-reactive|CD8|TCRαβ|repertoires	8
30575715	abstract	Structure|of|a|cross-reactive|TCR-HLA-B37-NP|338|complex|suggest|that|the|conserve|conformation|of|the|variant|underpin|TCR|cross-reactivity|.	cross-reactive|TCR-HLA-B37-NP|338|complex|TCR	5
